During the past decade, Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie" are "Amyotrophic Lateral Sclerosis" (2 trials), "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie" in a lesser frequency.

Most popular intervention types in "Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials), "Fenebrutinib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Deutsche Klinik für Diagnostik; DKD Helios Klinik Wiesbaden, Abt. Neurologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".